Pharmalot is reporting that AstraZeneca recently received FDA approval to market its Crestor cholesterol fighter as a preventive pill for millions of folks who don’t have high cholesterol. Not surprisingly, this has prompted some to wonder whether this is a good idea. For more on this go to a story in the
The New York Times. The skeptics point to concern that cholesterol meds may not be as safe as a preventive drug as previously believed for people who are at low risk of heart attacks or strokes. Others suggest the benefits may not outweigh side effects. Go
here for the full story.
No comments:
Post a Comment